Improving clinical endpoints with AI for quicker and more reliable clinical trials

Clinical trials are the way in which pharmaceutical companies ensure patients safety and measure the effectiveness of the treatment. In the last three years there has been a rise in decentralized clinical trials (DET). In this presentation the clinical artificial intelligence company Legit.Health reveals the work they have done along side the pharmaceutical company Almirall. By using computer vision during clinical trials they have uncovered a window into the future of clinical trials, with higher probability and lower costs.